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after having been completely dipped in wa-
ter. The foam material in our gas diffuser is
hydrophobic. Because of its elastic proper-
ties, the foam does not collapse even if it is
soaked, and as the gas is blown through the
diffuser large parts of its cell structure will
remain clear. If the gas diffuser gets partly
covered with tissue or blood, the carbon
dioxide gas will, according to the law of
least resistance, automatically be redirected
inside the diffuser foam to exit through a
clear part, and its function will remain.
Thus the hydrophobic and elastic proper-
ties of the gas diffuser enable it to function
well even if it is in direct contact with the
wet inner wound. Although the foam ma-
terial is hydrophobic, the foam may absorb
and store a liquid by capillary forces if it is
completely drowned and at the same time
compressed in the liquid, just as a car wash
sponge would. If the gas diffuser unexpect-
edly becomes soaked through with blood or
water, a short compression with the tip of a
finger will evacuate the fluid and restore
full function. The same does not hold true
for a wet gauze sponge because of its lack
of hydrophobic and elastic properties.
To sum up, the gauze sponge has inher-
ent properties that make it unsuitable for
carbon dioxide deairing. It stops function-
ing as a gas diffuser when it gets wet.
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Reply to the Editor:
We appreciate the comments of van der
Linden and Persson. They report their own
experiences with carbon dioxide protec-
tion, which support our intraoperative find-
ings and conclusions drawn from measure-
ments of intrathoracic gas concentrations.
They promote the use of a self-designed
tool to insufflate carbon dioxide with the
argument that a sponge used as a diffuser
could get wet and lose its diffusing prop-
erties. In our experience, a sponge-covered
infusion line sutured to the side of the
pericardium (as described in our article)
does not get wet; if it were to do so, it could
easily be replaced with a dry one.
However, avoidance of gas jets to reach
high and stable concentrations of carbon
dioxide can be achieved with other diffu-
sion devices as well, as we have shown
with a commercially available perforated
drain, with which we measured 93.7% 
6% at 4 L of flow. Regarding minimal
invasive procedures, the sponge-covered,
reusable Veress needle performed excel-
lently (reaching a mean concentration of
97.5%  2%), and problems related to wet
sponges were not observed. But of course,
there is plenty of room for new develop-
ments.
Sven Martens, MD
Klinikum der J. W. Goethe-Universitat
Klinik fur Thorax-Herz und Thorakale
Gefasschirurgie
Theodor Stern Kai 7
Frankfurt am Main D-60590, Germany
doi:10.1067/mtc.2003.456
Thromboembolic complications after
beating heart coronary artery bypass
operations
To the Editor:
Beating heart coronary artery bypass sur-
gery (OPCAB) is gaining wider acceptance
because of the potential benefits of elimi-
nating cardiopulmonary bypass and its del-
eterious effects. The report of Cartier and
Robitaille1 is therefore interesting and adds
to the genuine perturbations of this tech-
nique. However, some aspects of the study
raise concern.
Cartier and Robitaille conducted a ret-
rospective study of the thromboembolic
complications after OPCAB and compared
it with a selected group of patients who had
coronary artery bypass grafting using car-
diopulmonary bypass (CABG). They re-
ported the incidence of thrombotic compli-
cations as 1% in 500 OPCAB patients in a
4-year period and 0.5% in 1476 CABG
patients selected from the latter 2 years of
the study period. Admittedly, 3 of the 5
OPCAB patients in whom thrombotic com-
plications developed had predisposing fac-
tors. Two had deep vein thrombosis ipsi-
lateral to the leg where a preoperative intra-
aortic balloon pump was inserted. The third
had chronic renal failure and was being
treated by hemodialysis.
No prophylactic regimen for preventing
thromboembolism was adopted in the OP-
CAB patients in this study.
The retrospective study of the preva-
lence of postoperative thromboembolic
complications is hindered by the nature of
the investigation. There are many symp-
tom-free patients with thromboembolism
(up to 44.8% of patients have deep vein
thrombosis after CABG)2 that will be
missed. Also, there are patients with mild
symptoms who would not have been inves-
tigated appropriately, and yet others who
have thromboembolic complications after
hospital discharge and receive treatment at
a different facility.
The selection of the CABG patients for
comparison with the OPCAB group is wor-
risome. The CABG patients were chosen
from a fraction of the study period for the
OPCAB patients, and little is known about
the patient characteristics and operative
and postoperative variables of the two
groups. Comparing these unmatched heter-
ogeneous groups of patients who had dif-
ferent surgical myocardial revasculariza-
tion techniques, operating times, and
intraoperative and postoperative manage-
ment, without controlling for effect modi-
fication by these variables, will prejudice
the result.
It has been suggested that patients who
have leg vein harvest demonstrate circula-
tory disturbances in the venous system of
the donor legs.3 This, combined with leg
wound problems and, sometimes, delayed
mobilization, distinguishes the patient with
saphenous vein harvest from the patient
whose leg veins were not harvested. This
also adds to the heterogeneity of the
groups.
Thromboembolic prophylaxis is effec-
tive in patients undergoing cardiac surgery4
and is commonplace. The authors eruditely
enunciated a formidable and impressive
discussion of the hypercoagulability of ma-
jor tissue trauma and median sternotomy,
which are integral to cardiac surgery. It is
therefore intriguing that the OPCAB pa-
tients did not receive any prophylaxis
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against thromboembolism. This possibly
contributes to the difference in the inci-
dence of thromboembolic complications
between the two groups.
This study has not shown compelling
evidence in support of its claim. It probably
emphasizes the importance of prophylaxis
for thromboembolism in high-risk patients
undergoing OPCAB.
D. L. Ngaage, MB, BS, FWACS, FRCS
Department of Cardiothoracic Surgery
Yorkshire Heart Center
Leeds General Infirmary
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Reply to the Editor:
Dr Ngaage brought up interesting remarks
that we would like to address. The two
cohorts of patients that we compared were
not exactly selected. The beating heart cor-
onary artery bypass (OPCAB) cohort in-
cluded 500 consecutive cases of coronary
artery revascularization representing 95%
of all traditiional coronary artery bypass
graft (CABG) cases done by our group
during that period (98% for 1999 and
2000). Only very hemodynamically unsta-
ble patients requiring high doses of inotro-
pic drugs or patients having specific technical
difficulties, such as deep intramyocardial in-
ternal thoracic artery or tight posterior adhe-
sions precluding safe dissection, were re-
jected for the OPCAB approach. The cohort
of patients in whom cardiopulmonary bypass
(CPB) was used comprised all patients oper-
ated on from April 1998 through March 2000
(corresponding to 2 “clerical years” for the
archive department) who underwent CABG
on CPB with no other associated procedures.
No cases were excluded. Therefore, these
two cohorts were obviously not matched.
However, they were not “selected” or “cho-
sen” either. Furthermore, as seen in Tables 1
and 2, they were both comparable in terms of
preoperative risk factors and surgical data.
Preoperative intra-aortic balloon pumping
was used more often in the OPCAB group,
but postoperative balloon pumping use was
more frequent in the CPB groups. Globally,
the perioperative use of balloon pumps was
comparable (7.8% vs 6.4%, P .33) for both
groups.
We are aware that most of the throm-
boembolic complications occurring postop-
eratively are not clinically detected. Be-
cause this study was retrospective, we were
limited in clinical manifestations of venous
thromboembolic disease as they were re-
ported in the patients’ charts. These are the
manifestations that are important and mat-
ter for both the patients and the clinicians.
For clerical purposes, events were similarly
reported for both groups. For a vast major-
ity (95%) of patients, the saphenous vein
was also harvested and used as a vascular
conduit, regardless of the technique used,
which consequently should not be taken as
a heterogeneous issue. In our practice at the
Montreal Heart Institute, thromboembolic
prophylaxis has never been routinely used
for either on-pump or off-pump cases. Em-
phasis was put on early mobilization and
physiotherapist care. No patients in either
cohort reported in the current study re-
ceived any prophylaxis against thrombo-
embolism. Whether this was good or
TABLE 2. Surgical data for OPCAB and CPB patients
OPCAB CPB
P
value
Grafts/patient 3.08 0.89 2.91/0.67 .006
Ischemic time
(min)
30 11 43 16 .001
Grafts/territory 1.16 0.26 1.14 0.34 .25
Postop IABP
(%)
0.8 2.9 .01
TABLE 1. Demographics and preoperative risk factors for OPCAB and CPB
patients
OPCAB CPB
P
value
Age (y) 64 10 63 9 NS
Sex ratio 3.54 3.71 NS
Diabetes (%) 25 21 NS
HBP (%) 47 54 NS
Tobacco (%) 32 29 NS
COPD (%) 11 9 NS
Redo (%) 7 7 NS
MI 30 days (%) 16 18 NS
Previous CVA (%) 9 7.3 NS
Carotid bruit (%) 16 13 NS
PVD (%) 19 14 NS
Unstable angina (%) 68 72 .05
LVEF (%) 54 13 54 15 NS
LVEF 40% (%) 14 17 NS
Left main 50% (%) 30 28 NS
Preoperative IABP
(%)
7 3.5 .05
Territory involved 2.7 0.6 2.6 0.54 NS
HBP, High blood pressure; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction;
CVA, cerebrovascular accident; PVD, peripheral vascular disease; LVEF, left ventricular ejection
fraction; IABP, intra-aortic balloon pump; NS, not significant.
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